Thermoanalytical investigation of olanzapine compatibility with excipients used in solid oral dosage forms

Journal of Thermal Analysis and Calorimetry

Volumn 104, Issue 1, 2011, Pages 255-260

  Peres Filho, Marco Júnio ^a   Gaeti, Marilisa Pedroso Nogueira ^a   De Oliveira, Stela Ramirez ^a   Marreto, Ricardo Neves ^a   Lima, Eliana Martins ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Compatibility; DSC; Olanzapine; Solid pharmaceutical dosage forms; TGA; X ray powder diffraction

Indexed keywords

CHEMICAL INCOMPATIBILITY; COMPATIBILITY; DICALCIUM PHOSPHATE DIHYDRATE; DSC; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; OLANZAPINE; ORAL DOSAGE; PHARMACEUTICAL FORMULATION; POWDER X RAY DIFFRACTION; SOLID DOSAGE FORMS; TGA; THERMAL ANALYSIS TECHNIQUES; THERMOANALYTICAL METHODS; THERMOGRAVIMETRY;

CHEMICAL ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; DIFFRACTION; DRUG DOSAGE; MAGNESIUM; SUGARS; THERMOGRAVIMETRIC ANALYSIS; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION; X RAYS;

DRUG PRODUCTS;

EID: 79953210014     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10973-010-1245-3     Document Type: Conference Paper

References (31)

1. P Mura P Gratteri MT Faucci 2002 Compatibility studies of multicomponent tablet formulations-DSC and experimental mixture design J Therm Anal Calorim 68 541 551 10.1023/A:1016048021064 1:CAS:528:DC%2BD38XkvFegs7k%3D (Pubitemid 34614453)
2. FD Freire CFS Aragão TFAL Moura FN Raffin 2009 Compatibility study between chlorpropamide and excipients in their physical mixtures J Therm Anal Calorim 97 355 357 10.1007/s10973-009-0258-2 1:CAS:528:DC%2BD1MXht1OgurzI
3. P Mura MT Faucci A Manderioli G Bramanti L Ceccarelli 1998 Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy J Pharm Biomed Anal 18 151 163 10.1016/S0731-7085(98)00171-X 1:CAS:528: DyaK1cXotVOgs7w%3D (Pubitemid 28529332)
4. MSS Cunha-Filho R Martínez-Pacheco M Landín 2007 Compatibility of the antitumoral β-lapachone with different solid dosage forms excipients J Pharm Biomed Anal 45 590 598 10.1016/j.jpba.2007.08.016 1:CAS:528:DC%2BD2sXht1Grs7vN (Pubitemid 350007950)
5. F Monajjemzadeh D Hassanzadeh H Valizadeh MR Siahi-Shadbad JS Mojarrad TA Robertson MS Roberts 2009 Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets Eur J Pharm Biopharm 73 404 413 10.1016/j.ejpb.2009.06.012 1:CAS:528:DC%2BD1MXhtlCntLfI
6. RLO Rezende MIRM Santoro JR Matos 2008 Stability and compatibility study on enalapril maleate using thermoanalytical techniques J Therm Anal Calorim 93 881 886 10.1007/s10973-007-8187-4 1:CAS:528:DC%2BD1cXhtF2gtL7E
7. HK Stulzer MP Tagliari AP Cruz MAS Silva MCM Laranjeira 2008 Compatibility studies between piroxicam and pharmaceutical excipients used in solid dosage forms Pharm Chem J 42 215 219 10.1007/s11094-008-0091-0 1:CAS:528:DC%2BD1cXht1aisb3J
8. K Jackson D Young S Pant 2003 Drug-excipient interactions and their affect on absorption Pharm Sci Technol Today 3 10 336 345 10.1016/S1461-5347(00) 00301-1
9. ATM Serajuddin AB Thakur RN Ghoshal MG Fakes SA Ranadive KR Morris SA Varia 1999 Selection of solid dosage form composition through drug-excipient compatibility testing J Pharm Sci 88 7 696 704 10.1021/js980434g 1:CAS:528:DyaK1MXjtFegsLY%3D (Pubitemid 29325996)
10. A Marini V Berbenni S Moioli G Bruni P Cofrancesco C Margheritis M Villa 2003 Drug-excipient compatibility studies by physico-chemical techniques-the case of indomethacin J Therm Anal Calorim 73 529 545 10.1023/A:1025426012578 1:CAS:528:DC%2BD3sXnslGisbo%3D
11. D Kiss R Zelkó C Novák Z Éhen 2006 Application of DSC and NIRS to study the compatibility of metronidazole with different pharmaceutical excipients J Therm Anal Calorim 84 2 447451 10.1007/s10943-005- 7257-9 (Pubitemid 43724305)
12. M Tomassetti A Catalani V Rossi S Vecchio 2005 Thermal analysis study of the interactions between acetaminophen and excipients in solid dosage forms and in some binary mixtures J Pharm Biomed Anal 37 949 955 10.1016/j.jpba.2004.10. 008 1:CAS:528:DC%2BD2MXjs1Klsrk%3D (Pubitemid 40614824)
13. P Mura S Furlanetto M Cirri F Maestrelli AM Marras S Pinzauti 2005 Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design J Pharm Biomed Anal 37 65 71 10.1016/j.jpba.2004.09.047 1:CAS:528: DC%2BD2MXmsVKrtA%3D%3D (Pubitemid 40138717)
14. ME Brown EM Antunes BD Glass M Lebete RB Walker 1999 DSC screening of potential prochlorperazine-excipient interactions in preformulation studies J Therm Anal Calorim 56 1317 1322 10.1023/A:1010150305542 1:CAS:528: DyaK1MXnt1Wms74%3D
15. RK Verma S Garg 2005 Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing J Pharm Biomed Anal 38 633 644 10.1016/j.jpba.2005.02.026 1:CAS:528:DC%2BD2MXlsFCmu7c%3D (Pubitemid 40835561)
16. PR Oliveira HK Stulzer LS Bernardi SHM Borgmann SG Cardoso MAS Silva 2010 Sibutramine hydrochloride monohydrate-thermal behavior, decomposition kinetics and compatibility studies J Therm Anal Calorim 100 1 277 282 10.1007/s10973-009-0200-7 1:CAS:528:DC%2BC3cXkslKlt70%3D
17. D Giron 2002 Applications of thermal analysis and coupled techniques in pharmaceutical industry J Therm Anal Calorim 68 335 357 10.1023/A:1016015113795 1:CAS:528:DC%2BD38XkvFehurk%3D (Pubitemid 34614439)
18. F Balestrieri AD Magri AL Magri D Marini A Sacchini 1996 Application of differential scanning calorimetry to the study of drug-excipient compatibility Thermochim Acta 285 337 345 10.1016/0040-6031(96)02904-8 1:CAS:528: DyaK28XmtVyrurk%3D (Pubitemid 126316647)
19. P Mura A Manderioli G Bramanti S Furlanetto S Pinzauti 1995 Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients Int J Pharm 119 71 79 10.1016/0378-5173(94)00374-E 1:CAS:528:DyaK2MXkvFGqt7c%3D
20. G Bruni L Amici V Berbenni A Marini A Orlandi 2002 Drug-excipient compatibility studies-search of interaction indicators J Therm Anal Calorim 68 561 573 10.1023/A:1016052121973 1:CAS:528:DC%2BD38XkvFegsL8%3D (Pubitemid 34614455)
21. M Mitchell R Riesenberg MA Bari E Marquez D Kurtz D Falk T Hardy CC Taylor CP Mitchell P Cavazzoni 2006 A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects Clin Ther 28 6 881 892 10.1016/j.clinthera.2006.06.008 1:CAS:528:DC%2BD28Xot1aitbk%3D (Pubitemid 44062696)
22. ® Brand council I. http://www.furiousseasons.com/ zyprexa%20documents/ZY200370406.pdf (2003). Accessed 15 Feb 2007.
23. GI Spielmans 2009 The promotion of olanzapine in primary care: an examination of internal industry documents Soc Sci Med 69 14 20 10.1016/j.socscimed.2009.05.001
24. SM Reutzel-Edens JK Bush PA Magee GA Stephenson SR Byrn 2003 Anhydrates and hydrates of olanzapine: crystallization, solid-state characterization, and structural relationships Cryst Growth Des 3 6 897 907 10.1021/cg034055z 1:CAS:528:DC%2BD3sXltVWltbc%3D (Pubitemid 37467740)
25. GI Polla DR Vega H Lanza DG Tombari R Baggio AP Ayala JM Filho D Fernandez G Leyva G Dartayet 2005 Thermal behaviour and stability in olanzapine Int J Pharm 301 33 40 10.1016/j.ijpharm.2005.05.035 1:CAS:528: DC%2BD2MXptVWht7k%3D (Pubitemid 41206588)
26. I Wawrzycka-Gorczyca P Borowski J Osypiuk-Tomasik L Mazur AE Koziol 2007 Crystal structure of olanzapine and its solvates. Part 3. Two and three-component solvates with water, ethanol, butan-2-ol and dichloromethane J Mol Struct 830 188 197 10.1016/j.molstruc.2006.07.017 1:CAS:528: DC%2BD2sXhsF2gurc%3D (Pubitemid 46216333)
27. M Tiwari G Chawla AK Bansal 2007 Quantification of olanzapine polymorphs using powder X-ray diffraction technique J Pharm Biomed Anal 43 865 872 10.1016/j.jpba.2006.08.030 1:CAS:528:DC%2BD2sXht1Olurs%3D (Pubitemid 46185788)
28. H Larhrib XM Zeng GP Martin C Marriott J Pritchard 1999 The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate Int J Pharm 191 1 14 10.1016/S0378-5173(99)00164-7 1:CAS:528:DyaK1MXotVGjs78%3D (Pubitemid 29502173)
29. HK Stulzer PO Rodrigues TM Cardoso JSR Matos MAS Silva 2008 Compatibility studies between captopril and pharmaceutical excipients used in tablets formulations J Therm Anal Calorim 91 323 328 10.1007/s10973-006-7935-1 1:CAS:528:DC%2BD1cXhsFansrc%3D (Pubitemid 351199257)
30. LS Bernardi PR Oliveira FS Murakami MAS Silva SHM Borgmann SG Cardoso 2009 Characterization of venlafaxine hydrochloride and compatibility studies with pharmaceutical excipients J Therm Anal Calorim 97 729 733 10.1007/s10973-009-0282-2 1:CAS:528:DC%2BD1MXhtlWns73M
31. A Flemming KM Picker-Freyer 2008 Compaction of lactose drug mixtures: quantification of the extent of incompatibility by FT-Raman spectroscopy Eur J Pharm Biopharm 68 802 810 10.1016/j.ejpb.2007.07.012 1:CAS:528: DC%2BD1cXjtVekt7g%3D (Pubitemid 351318202)